Vastagbélrák: vizsgálatok itt: Izrael
19 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - 3. fázisTaking peopleA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Where
- Beer Yaakov, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06662786 · EU 2024-513852-13-00 - 3. fázisTaking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Beer Yaakov, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - 2. fázisTaking peopleA Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Where
- Haifa, Jerusalem, Petah Tikva, Tel Aviv
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- AbbVie
See details and how to joinNCT06820463 · EU 2024-512981-33-00 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Haifa, Tel Aviv
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - 3. fázisTaking peopleSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Where
- Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Beersheba, Haifa, Jerusalem, Petah Tikva, Tel Aviv, Tsrifin
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 1/2. fázisTaking peopleSafety of HRX215 in Patients After Minor and Major Liver Resection
- Where
- Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év to 75 év
- People
- 80 worldwide
- Run by
- HepaRegeniX GmbH
See details and how to joinNCT06638502 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Haifa, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Tel Aviv
- Életkor
- 18 év to 100 év
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - 1. fázisTaking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - No phaseTaking peopleEfficacy and Safety of the CG-100 Intraluminal Bypass Device
- Where
- Beersheba
- Életkor
- 22 év to 70 év
- People
- 250 worldwide
- Run by
- Colospan Ltd.
See details and how to joinNCT04184973 - 1. fázisTaking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Beer Ya'akov, Haifa, Jerusalem, Kefar Sava, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - 4. fázisTaking peopleTranexamic Acid During Colonic Endoscopic Resection Procedures
- Where
- Be’er Ya‘aqov
- Életkor
- 18 év and over
- People
- 200
- Run by
- Assaf-Harofeh Medical Center
See details and how to joinNCT05345613 - No phaseNot yet taking people in IzraelDelayed Surveillance Colonoscopy Following Piecemeal EMR
- Where
- Haifa
- Életkor
- 18 év and over
- People
- 760
- Run by
- Rambam Health Care Campus
See details and how to joinNCT07328308 - 1/2. fázisTaking peopleAutologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 50
- Run by
- Hadassah Medical Organization
See details and how to joinNCT00722228 - 2. fázisTaking peopleTotal Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
- Where
- Petah Tikva
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- brenner baruch
See details and how to joinNCT06940388 · EU 2025-522120-28-00 - No phaseNot yet taking people in IzraelHepatopulmonary Radio-sterilization With Immunotherapy
- Where
- Ramat Gan
- Életkor
- 18 év and over
- People
- 44
- Run by
- Sheba Medical Center
See details and how to joinNCT06053996 - 2. fázisTaking peopleColorectal Metastasis Prevention International Trial 2
- Where
- Afula, Haifa, Petah Tikva, Tel Aviv, Tel HaShomer, Tsrifin
- Életkor
- 20 év to 80 év
- People
- 200
- Run by
- Assaf-Harofeh Medical Center
See details and how to joinNCT03919461